EVO Viva ICL | One Eye (PF only) - ROQUE Eye Clinic | Manila, Philippines
✕
✕
✕
BGC: +63 (917) 844-2020
ALABANG: +63 (998) 997-2020
✕
✕

EVO Viva ICL | One Eye (PF only)

EVO VIVA ICL

OVERVIEW

EVO Viva is an implantable Collamer lens with an extended-depth-of-focus design intended to broaden the range of vision in suitable patients with myopia and presbyopia. Reading glasses may still be needed, particularly for small print, prolonged reading or demanding near tasks. Suitability and expected results depend on eye anatomy, prescription, visual needs and the applicable labeling for the exact lens supplied. Implantation is surgery inside the eye and carries risks.

TERMS AND CONDITIONS, INCLUSIONS, AND EXCLUSIONS

1. Service includes EVO VIVA ICL implantation for one eye and surgeon professional services only. 2. The published price refers to a discounted ICL surgical package inclusive of surgeon’s professional fee, ICL and hospital fees. The final net amount may no longer be reduced with further discounts, such as Senior Citizen or PWD benefits. 3. If the procedure is performed under general anesthesia, a 28,000 premium is added to the surgeon’s professional fee, on top of the additional hospital fees and anesthesiologist's fees. 4. Final surgical planning requires complete ophthalmic evaluation and diagnostics. Visual outcomes vary and are not guaranteed. 5. When applicable, PhilHealth pre-approval is required. Insurance or HMO cases require an approved letter of authority or guarantee letter before the procedure. 6. A daily hospital room rate charge applies to all admissions and is billed separately by the hospital based on room type and length of stay.

CONTACT INFORMATION

Dr. Manolette Roque | Dr. Barbara Roque St. Luke’s Medical Center – Global City 2nd Floor, Units 217-218, Roque Eye Clinic, Medical Arts Building Rizal Drive cor. 5th Ave, Taguig City 1634, Philippines +63-917-844-2020 +63-998-998-2020 +63-2-8828-2020 +63-2-8789-7700 ext. 7217 +63-2-8789-7700 ext. 7218

Dr. Manolette Roque | Dr. Barbara Roque Asian Hospital and Medical Center 5th Floor, Unit 509, Roque Eye Clinic, Medical Office Building 2205 Civic Drive, Alabang, Muntinlupa City 1781, Philippines +63-917-795-2020 +63-998-997-2020 +63-2-8771-9253 +63-2-8771-9000 ext. 7509

EVO VIVA ICL

EVO Viva is an implantable Collamer lens with an extended-depth-of-focus design intended to broaden the range of vision in suitable patients with myopia and presbyopia. Reading glasses may still be needed, particularly for small print, prolonged reading or demanding near tasks. Suitability and expected results depend on eye anatomy, prescription, visual needs and the applicable labeling for the exact lens supplied. Implantation is surgery inside the eye and carries risks.

WHAT EVO VIVA ICL CORRECTS

EVO Viva is designed to extend the range of vision in suitable patients, including some patients with myopia and presbyopia. Reading glasses may still be needed, particularly for small print, prolonged reading or demanding near tasks. The result depends on the eye, prescription, visual demands and lens plan.

HOW THE PROCEDURE WORKS

The ophthalmologist performs a detailed eye evaluation to confirm eligibility. During the procedure, the surgeon creates a small corneal incision and inserts the foldable lens into the eye. The lens rests behind the iris and in front of the natural lens. This approach preserves corneal structure and the lens may be removed or exchanged through another operation when clinically indicated. Removal carries risks and does not guarantee restoration of the eye’s previous condition.

WHO MAY BENEFIT

EVO VIVA ICL suits patients who are not ideal candidates for LASIK or PRK. It also serves patients who prefer a cornea-preserving option. This procedure may benefit the following individuals.

1. Patients with moderate to high myopia
2. Individuals with thin or borderline corneas
3. Patients seeking improved distance and intermediate vision
4. Adults with stable prescriptions
5. Patients who prefer a removable or exchangeable lens. The lens may be removed or exchanged through another operation when clinically indicated. Removal has its own risks and does not guarantee restoration of the eye’s previous condition.

RECOVERY AND EXPECTED OUTCOMES

Patients often notice visual improvement soon after surgery. Most patients resume normal activities within a short recovery period. Vision continues to stabilize over time, and scheduled follow-up visits ensure proper healing. Reading glasses may still be needed for some near tasks. Discuss the expected range of vision for your individual treatment plan.

SAFETY AND CLINICAL CONSIDERATIONS

The EVO VIVA ICL includes ultraviolet protection and a central port that supports natural fluid flow. Proper screening ensures adequate eye anatomy and stable eye pressure. Risks include infection, inflammation, pressure changes, and lens-related complications. The ophthalmologist determines final suitability after complete diagnostics.

EVO VIVA ICL

EVO Viva is an implantable Collamer lens with an extended-depth-of-focus design intended to broaden the range of vision in suitable patients with myopia and presbyopia. Reading glasses may still be needed, particularly for small print, prolonged reading or demanding near tasks. Suitability and expected results depend on eye anatomy, prescription, visual needs and the applicable labeling for the exact lens supplied. Implantation is surgery inside the eye and carries risks.

WHAT EVO VIVA ICL CORRECTS

EVO Viva is designed to extend the range of vision in suitable patients, including some patients with myopia and presbyopia. Reading glasses may still be needed, particularly for small print, prolonged reading or demanding near tasks. The result depends on the eye, prescription, visual demands and lens plan.

HOW THE PROCEDURE WORKS

The ophthalmologist performs a detailed eye evaluation to confirm eligibility. During the procedure, the surgeon creates a small corneal incision and inserts the foldable lens into the eye. The lens rests behind the iris and in front of the natural lens. This approach preserves corneal structure and the lens may be removed or exchanged through another operation when clinically indicated. Removal carries risks and does not guarantee restoration of the eye’s previous condition.

WHO MAY BENEFIT

EVO VIVA ICL suits patients who are not ideal candidates for LASIK or PRK. It also serves patients who prefer a cornea-preserving option. This procedure may benefit the following individuals.

1. Patients with moderate to high myopia
2. Individuals with thin or borderline corneas
3. Patients seeking improved distance and intermediate vision
4. Adults with stable prescriptions
5. Patients who prefer a removable or exchangeable lens. The lens may be removed or exchanged through another operation when clinically indicated. Removal has its own risks and does not guarantee restoration of the eye’s previous condition.

RECOVERY AND EXPECTED OUTCOMES

Patients often notice visual improvement soon after surgery. Most patients resume normal activities within a short recovery period. Vision continues to stabilize over time, and scheduled follow-up visits ensure proper healing. Reading glasses may still be needed for some near tasks. Discuss the expected range of vision for your individual treatment plan.

SAFETY AND CLINICAL CONSIDERATIONS

The EVO VIVA ICL includes ultraviolet protection and a central port that supports natural fluid flow. Proper screening ensures adequate eye anatomy and stable eye pressure. Risks include infection, inflammation, pressure changes, and lens-related complications. The ophthalmologist determines final suitability after complete diagnostics.